Clinical evidence has established a positive correlation between elevated IGF-1Rs in prostate stroma tissue and Gleason grade, and down-regulation of epithelial IGFBP3 in prostate cancer patients [50]. This evidence concerns the gene IGFBP3 and prostate carcinoma.